Cannabis Law Report

JANUARY 7, 2021

New Frontier Data is proud to present: Cannabis In America For 2021 & Beyond: A New Normal in Consumption & Demand.… The post New Publication From New Frontier Data: Cannabis in America For 2021 & Beyond: A New Normal in Consumption & Demand first appeared on Cannabis Law Report. Here’s the blurb.

Consumption 98

Consumption Data Law Cannabis 98

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

DECEMBER 7, 2020

Here’s the blurb… New Frontier Data is proud to present: Cannabis In America For 2021 & Beyond: A New Normal in Consumption & Demand. The post New Frontier Data Publish New Report: Cannabis In America For 2021 & Beyond: A New Normal in Consumption & Demand. Topics … Read More.

Consumption 75

Consumption Data Topical Law 75

Cannabis Law Report

MAY 19, 2020

THE PRICE – Free THE DATE – Wednesday, May20th, at 10 AM EST | 3:00 PM GMT THE RATING – THE BLURB – In this … Read More.

Data 98

Data CBD 98

Cannabis Law Report

SEPTEMBER 14, 2020

New Frontier Data is proud to partner with the industry leader in water-soluble CBD and hemp emulsion technology, Sorse Technology, to present the report, Cannabis-Infused … Read More. The post Video: New Frontier Data sneak peek to cannabis industry report, EU CBD Consumer Report Series: Market Size & Demand.

Data 64

Data CBD Hemp Law 64

Cannabis Law Report

JUNE 16, 2020

New Frontier Data is proud to partner with Groff NA and Farmacy Partners to present: U.S. Hemp Market Report: Cannabinoids Edition, Volume 1. This report … Read More.

Data 59

Data Cannabinoids Hemp 59

Cannabis Law Report

MAY 26, 2022

This data helps Californians understand the work we have ahead of us in realizing the promises of cannabis legalization, including supporting access to a safe, legal, and equitable cannabis market across the state and combating the unregulated, illicit market”. The data tool can be found on the DCC website here: [link]. Tweet this.

Data 52

Data Access Business Retail 52

Medical Marijuana Program Connection

MAY 22, 2023

MONTREAL–(BUSINESS WIRE)–Inversago Pharma Inc. Inversago”), a leader in the development of peripherally-acting CB1 receptor (CB1r) blockers to address complications associated. Read More

Data 52

Data Business 52

Cannabis Law Report

NOVEMBER 26, 2019

Hemp cultivation, especially given the explosive demand arising from neighboring European nations, presents a unique opportunity to Zimbabwe and other African nations well positioned to meet such demand cheaper, and possibly faster, than current suppliers from Canada and Latin America.”. Here’s the press release in full.

Data 59

Data Cultivation Hemp Research and Development 59

Americans for Safe Access

MARCH 24, 2020

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

Cannabinoids 243

Cannabinoids Data Safety Patients 243

Cannabis Law Report

MAY 24, 2022

New Frontier Data, 2021 WL 5298006, Ct. New Ventures Growth Corporation (Ventures) entered into an agreement in 2018 with New Frontier Data (Frontier). Ventures, a California corporation, would provide data analytics and artificial intelligence software to be used on Frontier’s market research and analytical platforms.

Data 52

Data Programs Law Business 52

SpeedWeed

JULY 18, 2021

Although further research into the issue is clearly necessary, the present study indicates that fears over high-potency THC concentrates are likely unwarranted. The post High-Potency THC Concentrates Are Just As Safe As Regular-Potency Weed, More Data Shows appeared first on SpeedWeed. View original article.

Concentrates 98

Concentrates THC Data CBD 98

Cannabis Law Report

OCTOBER 15, 2021

At ASHG, Goldfinch Bio will give an oral presentation showcasing insights revealed by its Kidney Genome Atlas (KGA). At ASHG, Goldfinch Bio will give an oral presentation showcasing insights revealed by its Kidney Genome Atlas (KGA). Both meetings are being held virtually. President and Chief Executive Officer of Goldfinch Bio. “In

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

Cannabis Law Report

JUNE 24, 2021

In our latest report, Global Cannabis Trade: Emerging Regional Import & Export Opportunities , we reveal opportunities presented by the creation of the new legal markets and examine logistical challenges of crafting a safe and stable marketplace for consumers. .

Data 104

Data Environment Oil Policy 104

Medical Marijuana Program Connection

MARCH 20, 2023

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® ® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company developing groundbreaking therapies for the. Read More

Pharmaceutical 52

Pharmaceutical Data Therapy Business 52

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

SEPTEMBER 28, 2021

(the “Company”) (OTCQB: ZDPY), a leading real estate development firm for emerging and highly regulated industries including regulated cannabis, today announced Bryan McLaren, CEO, and Berekk Blackwell, COO, will present at Benzinga’s Cannabis Capital Conference on Friday, October 15, at 11:45 a.m.

Events 52

Events Hybrid Data Business 52

Cannabis Law Report

JUNE 1, 2023

Walsh The FDA held a “stakeholders” call on May 25 to present information on how it reached its present stance concerning CBD and to answer a few questions. FDA’s presentation included its assessment of survey data concluding that the predominant uses of CBD are ingestion resulting in multiple adverse health effects.

CBD 52

CBD Data 52

Cannabis Law Report

FEBRUARY 24, 2022

present an imminent health risk. A compliant inspection rating may be assigned even when observations are present. Table 1 gives inspection data for licence holders from April 1, 2019 to March 31, 2020. Table 1: Inspection data. Critical observations are those that are likely to: increase the immediate risk of diversion.

Compliance 52

Compliance Compliance Data Safety 52

Cannabis Law Report

AUGUST 3, 2021

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

Research and Development 105

Research and Development Data Conditions Therapy 105

Medical Marijuana Program Connection

FEBRUARY 28, 2023

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® ® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company developing groundbreaking therapies for the. Read More

Pharmaceutical 52

Pharmaceutical Therapy Data Business 52

Medical Marijuana Program Connection

JUNE 11, 2023

BORDEAUX, France–(BUSINESS WIRE)–Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of. Read More

Data 52

Data Business 52

Cannabis Law Report

JULY 7, 2019

New Frontier Data is proud to present The Latin America Regional Cannabis Report: 2019 Industry Outlook.

Data 40

Data Business Legalization Cannabis 40

Cannabis Law Report

DECEMBER 4, 2019

Based on her data, Dr. Snyder finds that requiring “Total THC” concentrations not to exceed 0.3%, rather than just limiting ?9-THC, This data shows that 97.4% (370 out of 380) samples fell at or below the 0.3% In this article, Dr. Snyder distills her analysis of hemp testing during the 2018 and 2019 growing seasons. HEMP VIABILITY.

Data 59

Data THC Strains Concentrates 59

NORML

JUNE 18, 2019

The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Israeli investigators assessed the use of cannabis over a six-month period in 211 patients with the disease.

Patients 279

Patients Therapy Data Safety 279

Cannabis Law Report

MARCH 13, 2020

Presented March 2 2020 here is the English preeamble. We committed to share data and I will highlight a few early observations: Michelle Boudreau. As Members are aware, Canada continues to implement our strict regulatory framework for cannabis, as a domestic public health approach. Michelle can be reached at 613-960-2496.

Education 64

Education Data Access Programs 64

Cannabis Law Report

NOVEMBER 2, 2022

The Art of Cannabis and Food Pairings Cannabis Presentation Session Can the Union of Equity and Tech Save Cannabis? Cannabis Panel Session Creating Robust Data Sets Cannabis Panel Session Culture, Legacy & Cannabis: Roadmap To Coexistence Cannabis Panel Session Green or Not? Here’s what you get. we’ll pass!

Law 72

Law Environment Data Food 72

Cannabis Law Report

JULY 26, 2021

This report seeks to establish and present the baseline measures for the metrics specified in S.B. The information presented here should be interpreted with caution. The majority of the data sources vary considerably in terms of what exists historically and the reliability of some sources has improved over time. 13-283 (C.R.S.

Legalization 111

Legalization Data Marijuana Safety 111

Cannabis Law Report

DECEMBER 2, 2021

IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.

Clinical Trials 52

Clinical Trials Data Patients THC 52

Veriheal

AUGUST 22, 2023

Ortega’s research meticulously analyzed data from ten states where adult-use cannabis has become legal. The data revealed that shortly after the adoption of recreational marijuana laws, states began to see fewer admissions to treatment centers for mental illness. This downward trend did not apply to a specific demographic.

Treatment 98

Treatment Legalization Policy Recreational 98

Illinois News Joint

OCTOBER 6, 2023

The Illinois Department of Agriculture (IDOA ) “will approve a craft grower’s request for an increase of canopy space based on the following criteria: The market need for additional cannabis production, as indicated by any of the following: Illinois adult use cannabis monthly sales figures Wholesale cannabis sales figures Inventory tracking data (..)

Packaging 93

Packaging Data Agriculture History 93

Cannabis Law Report

JULY 20, 2021

This report seeks to establish and present the baseline measures for the metrics specified in S.B. The information presented here should be interpreted with caution. The majority of the data sources vary considerably in terms of what exists historically and the reliability of some sources has improved over time. 13-283 (C.R.S.

Data 98

Data Legalization Marijuana Safety 98

NORML

APRIL 7, 2020

Incidences of the vaping-related lung illness EVALI (e-cigarette or vaping product use-associated lung injury) are primarily concentrated to jurisdictions where adult-use cannabis consumption is prohibited, according to data published in the Journal of the American Medical Association (JAMA) Network Open.

Vaping 281

Vaping Legalization Concentrates Access 281

Project CBD

AUGUST 6, 2019

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. CBD for hypertension. Related story Can CBD Help Your Condition? Preclinical promise.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Illinois News Joint

JANUARY 30, 2023

The new website includes dropdown menus for information about CROO Media , Research and Data , Legal and Enforcement , About , and Agencies. The Media information includes Press Releases, Newsletters, Reports and Public Presentations, and Upcoming Dates.

Media 87

Media Data Agriculture Recreational 87

Veriheal

NOVEMBER 21, 2023

Quemarr presents an emulsion-based drug delivery system tailored for cannabinoids and made to tackle America’s diabetes crisis. The buddie can be paired with a mobile app that tracks consumption, correlating it with health data from devices like WHOOP, Apple Watch, or Fitbit.

Research and Development 107

Research and Development Consumption Education Data 107